Durable SARS-CoV-2 B cell immunity after mild or severe disease

Multiple studies have shown loss of SARS-CoV-2 specific antibodies over time after infection, raising concern that humoral immunity against the virus is not durable. If immunity wanes quickly, millions of people may be at risk for reinfection after recovery from COVID-19. However, memory B cells (MB...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:medRxiv
Auteurs principaux: Ogega, Clinton O., Skinner, Nicole E., Blair, Paul W., Park, Han-Sol, Littlefield, Kirsten, Ganesan, Abhinaya, Ladiwala, Pranay, Antar, Annukka AR, Ray, Stuart C., Betenbaugh, Michael J., Pekosz, Andrew, Klein, Sabra L., Manabe, Yukari C., Cox, Andrea L., Bailey, Justin R.
Format: Artigo
Langue:Inglês
Publié: Cold Spring Harbor Laboratory 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605583/
https://ncbi.nlm.nih.gov/pubmed/33140070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.10.28.20220996
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires